We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+10.13%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$21.8B
AUM Growth
+$5.21B
Cap. Flow
+$2.91B
Cap. Flow %
13.39%
Top 10 Hldgs %
4.65%
Holding
3,639
New
851
Increased
1,058
Reduced
913
Closed
749

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$95.1M
2
ABBV icon
AbbVie
ABBV
+$88.9M
3
ABNB icon
Airbnb
ABNB
+$86.6M
4
WMT icon
Walmart Inc
WMT
+$85.7M
5
SCHW
Charles Schwab
SCHW
+$83.8M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$124M
2
ANET icon
Arista Networks
ANET
+$89.3M
3
PNC icon
PNC Financial Services
PNC
+$86.2M
4
TEAM icon
Atlassian
TEAM
+$72.5M
5
ONON icon
On Holding
ONON
+$65.2M

Sector Composition

Rank Sector Weight
1 Technology 7.59%
2 Industrials 6.49%
3 Financials 6.48%
4 Healthcare 4.91%
5 Consumer Discretionary 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMEA icon
2876
Biomea Fusion
BMEA
$91.3M
$1.53K ﹤0.01%
848
-115,839
-99% -$223K
TPIC
2877
DELISTED
TPI Composites
TPIC
$1.4K ﹤0.01%
+1,630
New +$1.66K
SCWO icon
2878
374Water
SCWO
$37.6M
$1.38K ﹤0.01%
+424
New +$1.43K
OVID icon
2879
Ovid Therapeutics
OVID
$491M
$1.28K ﹤0.01%
+3,874
New +$1.17K
GALT icon
2880
Galectin Therapeutics
GALT
$348M
$1.18K ﹤0.01%
+561
New +$839
FBLG icon
2881
FibroBiologics
FBLG
$6.5M
$1.15K ﹤0.01%
+92
New +$1.66K
IPSC icon
2882
Century Therapeutics
IPSC
$361M
$1.1K ﹤0.01%
+1,978
New +$1.06K
CEPT
2883
DELISTED
Cantor Equity Partners II
CEPT
$1.1K ﹤0.01%
+100
New +$1.13K
VRCA icon
2884
Verrica Pharmaceuticals
VRCA
$87.3M
$1.04K ﹤0.01%
+196
New +$1.05K
ABVEW
2885
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$1K ﹤0.01%
19,264
– –
BNZIW
2886
DELISTED
Banzai International Warrant
BNZIW
$554 ﹤0.01%
22,319
– –
CRNX icon
2887
Crinetics Pharmaceuticals
CRNX
$8.92B
$374 ﹤0.01%
+13
New +$401
CTNM
2888
Contineum Therapeutics
CTNM
$566M
$95 ﹤0.01%
+24
New +$104
OTLK icon
2889
Outlook Therapeutics
OTLK
$191M
$42 ﹤0.01%
+26
New +$41
A icon
2890
Agilent Technologies
A
$41.2B
– –
-84,067
Closed -$9.32M
AAOI icon
2891
Applied Optoelectronics
AAOI
$11.5B
– –
-284,688
Closed -$4.61M
AAT
2892
American Assets Trust
AAT
$1.4B
– –
-106,846
Closed -$2.15M
ABX
2893
Abacus Global Management
ABX
$913M
– –
-9,908
Closed -$74.2K
ABSI icon
2894
Absci
ABSI
$1.51B
– –
-288,460
Closed -$724K
ABVX
2895
Abivax
ABVX
$11.4B
– –
-10,152
Closed -$63.5K
ACB
2896
Aurora Cannabis
ACB
$185M
– –
-238,460
Closed -$1.05M
ACGL icon
2897
CALL
Arch Capital
ACGL
$33.6B
– –
-2,900
Closed -$279K
ACGL icon
2898
PUT
Arch Capital
ACGL
$33.6B
– –
-3,400
Closed -$327K
ACET icon
2899
Adicet Bio
ACET
$74.7M
– –
-775
Closed -$9.36K
ACHC icon
2900
CALL
Acadia Healthcare
ACHC
$2.94B
– –
-18,500
Closed -$561K
114 115
116
117 118

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q2 2025 Portfolio in Review

As of Q2 2025, Cubist Systematic Strategies held 3,639 positions worth $21.8B, up 31% from $16.5B the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

Cubist Systematic Strategies deployed $2.91B of net new capital in Q2 2025, opening 851 new positions and adding to 1,058 existing holdings. Its largest new stake was Mastercard: 171,877 shares worth $96.6M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Arista Networks, an estimated $89.3M trimmed.

  • Cubist Systematic Strategies's largest Q2 2025 buy was Mastercard: 171,877 shares worth $96.6M.
  • Cubist Systematic Strategies added most to FedEx in Q2 2025, an estimated $47.2M increase.
  • Cubist Systematic Strategies's biggest Q2 2025 reduction was Arista Networks, cutting an estimated $89.3M.
  • Cubist Systematic Strategies fully exited Broadcom in Q2 2025, selling an estimated $124M.
  • Cubist Systematic Strategies's ten largest holdings make up 4.7% of its $21.8B portfolio in Q2 2025.
  • Cubist Systematic Strategies opened 851 new positions and closed 749 in Q2 2025.
  • Cubist Systematic Strategies's portfolio value rose 31% quarter-over-quarter to $21.8B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.